Key Highlights

  • CrowdStrike Q1 FY2027 net new ARR rose 32% year-over-year to $256 million, exceeding guidance.
  • Full-year net new ARR outlook raised by over $52 million, with growth expected to accelerate over FY2026.
  • A 4-for-1 Stock Split was announced, effective July 2, 2026, on a split-adjusted trading basis.

CrowdStrike Holdings (Nasdaq: CRWD) shares declined 9.58% in pre-market trading on June 4, 2026, despite reporting a fiscal first quarter that beat expectations across every guided metric. The sell-off reflects a "priced for perfection" dynamic increasingly common among high-multiple technology names following strong but not transformational beats.

Q1 Results Exceed Expectations Across the Board

CrowdStrike delivered total Revenue of $1.39 billion in Q1 FY2027, up 26% year-over-year, marking the fourth consecutive quarter of accelerating revenue growth. Net new annual Recurring Revenue (ARR) reached a record $256 million, up 32% year-over-year, surpassing the top of guidance. Ending ARR climbed to $5.51 billion, growing at more than 24% year-over-year.

Non-GAAP Operating Income reached a Q1 record of $325.7 million, representing a 24% Operating Margin and a 530 basis point improvement over the prior year. Free Cash Flow hit an all-time record of $468.5 million, or 34% of revenue, supporting a Rule of 40 score of 59. The company also repurchased $176 million in shares during the quarter, with approximately $1.3 billion remaining under its buyback authorization.

The Mythos Inflection and AI-Driven Structural Demand

Management identified the "Mythos moment" as a structural inflection point for Cybersecurity demand. Following the release of Anthropic's Claude Mythos Preview model in April, CrowdStrike was selected as a founding security partner by both Anthropic and OpenAI, positioning the company as core AI infrastructure rather than a conventional cybersecurity vendor.

Chief Executive George Kurtz described a shift in how enterprises view cybersecurity: no longer primarily a risk management function, but a strategic enabler of AI adoption. AI detection and response, branded AI DR, saw ending ARR grow more than 250% sequentially with a Q2 pipeline already exceeding $50 million. Management indicated that AI DR could ultimately represent a larger market opportunity than endpoint detection and response.

Guidance Raised, but Q2 Falls Short of Street Expectations

For Q2 FY2027, CrowdStrike guided total revenue of $1.436 billion to $1.442 billion, reflecting 23% year-over-year growth. Net new ARR is expected in the range of $284 million to $286 million. While the full-year net new ARR outlook was raised by more than 500 basis points to reflect year-over-year growth acceleration over FY2026, some analysts noted the Q2 ARR guidance appeared below elevated Buy-Side expectations, contributing to the pre-market pressure.

For the full fiscal year, the company projects total revenue of $5.915 billion to $5.959 billion and non-GAAP Earnings-per-share/">Earnings Per Share of $4.88 to $4.96, or approximately $1.22 to $1.24 on a post-split basis.

Stock Split and Capital Allocation

CrowdStrike announced its first-ever stock split as a public company, a four-for-one forward split. Stockholders of record as of market close on June 25, 2026, will receive three additional shares for each share held, with split-adjusted trading commencing July 2, 2026.

Broader Sector Context

The pre-market decline also reflects sector-wide pressure on high-multiple technology names. Broadcom's simultaneous post-earnings drop of approximately 12% on unraised AI guidance added to sentiment headwinds across AI-adjacent stocks, creating a difficult tape environment even for companies reporting strong results.

Conclusion

CrowdStrike's Q1 FY2027 results demonstrate durable operational momentum, with accelerating revenue growth, record free cash flow, and a raised annual outlook. The pre-market decline appears more reflective of valuation expectations and sector sentiment than any fundamental deterioration. Investors will likely focus on whether AI DR adoption and the Mythos demand cycle can sustain the company's growth trajectory into the second half of FY2027.